Litcius/Paper detail

Adverse effects of brimonidine eye drop in children: A case series

Zahra Ghaffari, Zakaria Zakariaei, Monireh Ghazaeian, Reza Jafari, Neda Ezoddin, Hosnieh Yousefi Nouraee, Mohammad Reza Navaeifar

2021Journal of Clinical Pharmacy and Therapeutics13 citationsDOI

Abstract

WHAT IS KNOWN AND OBJECTIVE: Brimonidine is increasingly used in the treatment of intraocular hypertension. CASE SUMMARY: We report on five paediatric patients suffering from brimonidine eye drop intoxication. The most frequent signs of the intoxication were a lowered level of consciousness and hypotonia. Other complications were apnea, bradycardia, hypotension and seizure. One of the patients needed cardiopulmonary resuscitation. Apnea in one of the cases was resistant to naloxone. Pupils were unremarkable in two cases. WHAT IS NEW AND CONCLUSION: Brimonidine is potentially lethal for young infants. The absence of miosis and absence of response to naloxone is not a reason to rule out brimonidine poisoning.

Topics & Concepts

BrimonidineMedicine(+)-NaloxoneEye dropAnesthesiaBradycardiaMiosisOphthalmologyOpioidIntraocular pressureInternal medicineHeart rateReceptorBlood pressureGlaucoma and retinal disordersDrug-Induced Ocular ToxicityIntraocular Surgery and Lenses
Adverse effects of brimonidine eye drop in children: A case series | Litcius